1Polanski M, Anderson N L. A list of candidate cancer biomarkers for targeted proteomics[J]. Biomarker Insights, 2006, 2(1):1-48.
2Aebersold R, Anderson L, Caprioli R, et al. Perspective: a program to improve protein biomarker discovery for cancer[J]. J Proteome Res,2005, 4(4):1104-1109.
4Hanash S M, Pitteri S J, Faca V M. Mining the plasma proteome for cancer biomarkers[J]. Nature, 2008, 452(7187): 571-579.
5Syka J E, CoonJ J, Schroeder M J, et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry[J]. ProcNatl Acad SciUSA,2004, 101(26):9528-9533.
二级参考文献16
1Nelson DS.Autoantibodies in cancer patients[J]. Pathology,1997,8(2):155-160.
2Soussi T.p53 Antibodies in the sera of patients with various tupes of cancer : a review[J].Cancer Res,2000, 60(7): 1777-1788.
3Tominaga O, Unsal K, Zalcman G,et al. Detection of p73 antibodies in patients with various types of cancer: immunological characterization[J]. Br J Cancer,2001, 84(1):57-63.
4Yamaguchi K, Patturajan M, Trink B,et al. Circulating antibodies to p40 (AIS) in the sera of respiratory tract cancer patients[J]. Int J Cancer,2000 ,89(6):524-528.
5Von Mensdorff-Pouilly S, Snijdewint FG, Verstraeten AA,et al. Human MUC1 mucin: a multifaceted glycoprotein[J]. Int J Biol Markers,2000, 15(4):343-356.
6Marrais DJ, Rose RC, Lane C,et al. Seroresponses to human papillomavirus types 16,18,31,33, and 45 virus-like particles in south African women with cervical cancer and cervical intraepithelial neoplasia[J].J of Med. Vir,2002,60(3):403-410.
7Zumbach K, Hoffmann M, Kahn T,et al.Antibodies against oncoproteins E6 and E7 of human papillomavires types 16 and 18 in patients with head-and-neck squamous-cell carcinoma[J]. Int J Cancer,2000,85(6):815-818.
8Shinkura R, Yamamoto N, Koriyama C,et al.Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan[J]. J Med. Virol ,2000,60(4):411-416.
9Blaes F, Kiotz-M, Huwer H,et al.Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer[J]. Ann Thorac Surg,2000, 69(1):254-258
10Prasannan L, Misek DE, Hinderer R,et al.Identification of beta-tubulin isoforms as tumor antigens in neruoblastoma[J].Clin Cancer Res,2000, 6(10):3949-3956.
4Berkeman T,Stensted T. 2-D electrophoresis using immobilized pH gradients:principles and methods[M]. USA: Amersham Biosciences, 2001: 17-71.
5Gorg A,Obermaier C,Boguth G,et al. The current state of two-dimensional electrophoresis with immobilized pH gradients[J]. Electrophoresis, 2000, 21(6):1037-1053.
6Vergnes B, Gourbal B, Girard I, et al. A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death[J].Mol Cell Proteomics, 2007, 6(1):88-101.
7Calderwood S K, Ciocea D R. Heat shock proteins: stress proteins with Janus-like properties in cancer[J]. Int J Hyperthermia, 2008, 24(1):31-39.
8Kang Y, Taldone T, Clement C C, et al. Design of a fluorescence polarization assay platform for the study of human Hsp70[J]. Bioorg Med Chem Lett,2008,18(13):3749-3751.
9Langer R, Ott K, Specht K,et al. Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response[J].Clin Cancer Res, 2008,14(24):8279-8287.
